129 related articles for article (PubMed ID: 8080451)
1. (R)-5-fluoro-5,6-dihydrouracil: kinetics of oxidation by dihydropyrimidine dehydrogenase and hydrolysis by dihydropyrimidine aminohydrolase.
Porter DJ; Harrington JA; Almond MR; Lowen GT; Spector T
Biochem Pharmacol; 1994 Aug; 48(4):775-9. PubMed ID: 8080451
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyrimidine dehydrogenase. Kinetic mechanism for reduction of uracil by NADPH.
Porter DJ; Spector T
J Biol Chem; 1993 Sep; 268(26):19321-7. PubMed ID: 8366081
[TBL] [Abstract][Full Text] [Related]
3. Dehalogenating and NADPH-modifying activities of dihydropyrimidine dehydrogenase.
Porter DJ
J Biol Chem; 1994 Sep; 269(39):24177-82. PubMed ID: 7929074
[TBL] [Abstract][Full Text] [Related]
4. Determination of 5-fluorouracil and dihydrofluorouracil levels by using a liquid chromatography-tandem mass spectrometry method for evaluation of dihydropyrimidine dehydrogenase enzyme activity.
Serdar MA; Sertoğlu E; Uyanık M; Tapan S; Akın O; Cihan M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):525-9. PubMed ID: 21107571
[TBL] [Abstract][Full Text] [Related]
5. Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes.
Rosenbaum K; Jahnke K; Curti B; Hagen WR; Schnackerz KD; Vanoni MA
Biochemistry; 1998 Dec; 37(50):17598-609. PubMed ID: 9860876
[TBL] [Abstract][Full Text] [Related]
6. Preliminary examination of the influence of incubation time or cytosolic protein concentration on dihydropyrimidine dehydrogenase activity.
Tateishi T; Nakura H; Watanabe M; Tanaka M; Kumai T; Kobayashi S
Clin Chim Acta; 1996 Aug; 252(1):1-9. PubMed ID: 8814356
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil.
Spector T; Cao S; Rustum YM; Harrington JA; Porter DJ
Cancer Res; 1995 Mar; 55(6):1239-41. PubMed ID: 7882316
[TBL] [Abstract][Full Text] [Related]
8. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice.
Innocenti F; Danesi R; Bocci G; Natale G; Del Tacca M
Toxicol Appl Pharmacol; 2005 Mar; 203(2):106-13. PubMed ID: 15710171
[TBL] [Abstract][Full Text] [Related]
10. Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes.
Fischel JL; Formento P; Ciccolini J; Etienne-Grimaldi MC; Milano G
Anticancer Drugs; 2004 Nov; 15(10):969-74. PubMed ID: 15514566
[TBL] [Abstract][Full Text] [Related]
11. Stereochemistry of NADPH oxidation by dihydropyrimidine dehydrogenase from pig liver.
Podschun B
Biochem Biophys Res Commun; 1992 Jan; 182(2):609-16. PubMed ID: 1734873
[TBL] [Abstract][Full Text] [Related]
12. Development, validation and application of a novel liquid chromatography tandem mass spectrometry assay measuring uracil, 5,6-dihydrouracil, 5-fluorouracil, 5,6-dihydro-5-fluorouracil, α-fluoro-β-ureidopropionic acid and α-fluoro-β-alanine in human plasma.
Chavani O; Jensen BP; Strother RM; Florkowski CM; George PM
J Pharm Biomed Anal; 2017 Aug; 142():125-135. PubMed ID: 28501750
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.
Casale F; Canaparo R; Serpe L; Muntoni E; Pepa CD; Costa M; Mairone L; Zara GP; Fornari G; Eandi M
Pharmacol Res; 2004 Aug; 50(2):173-9. PubMed ID: 15177306
[TBL] [Abstract][Full Text] [Related]
14. The activity of dihydropyrimidine dehydrogenase from rat liver was not affected by any of five 5-hydroxytryptamine antagonists.
Tateishi T; Nakura H; Watanabe M; Tanaka M; Kumai T; Kobayashi S
Cancer Lett; 1996 Nov; 108(1):1-5. PubMed ID: 8950202
[TBL] [Abstract][Full Text] [Related]
15. Role of enzymatically catalyzed 5-iodo-5,6-dihydrouracil ring hydrolysis on the dehalogenation of 5-iodouracil.
Kim BD; Keenen S; Bodnar JK; Sander EG
J Biol Chem; 1976 Nov; 251(22):6909-14. PubMed ID: 993199
[TBL] [Abstract][Full Text] [Related]
16. [Assay method for uracil, dihydrouracil, 5-fluorouracil and 5-fluoro-5, 6-dihydrouracil by high-performance liquid chromatography].
Nakamura A; Kikuchi K; Ohishi T; Masuike T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):381-6. PubMed ID: 15045945
[TBL] [Abstract][Full Text] [Related]
17. A predictive biomarker for altered 5-fluorouracil pharmacokinetics following repeated administration in a rat model of colorectal cancer.
Kobuchi S; Kuwano S; Imoto K; Okada K; Nishimura A; Ito Y; Shibata N; Takada K
Biopharm Drug Dispos; 2013 Oct; 34(7):365-76. PubMed ID: 23836081
[TBL] [Abstract][Full Text] [Related]
18. In vitro degradation of pyrimidine bases: studies of rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Adv Exp Med Biol; 1986; 195 Pt B():245-8. PubMed ID: 3766229
[No Abstract] [Full Text] [Related]
19. Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.
Jiang H; Lu J; Ji J
Br J Pharmacol; 2004 Feb; 141(4):616-23. PubMed ID: 14744810
[TBL] [Abstract][Full Text] [Related]
20. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]